FibroBiologics Announces IND-Enabling Updates From Psoriasis Research Program Demonstrating Potential Of Human Dermal Fibroblast Spheroids As Novel Therapeutic Approach For Chronic-Relapse Psoriasis.
Author: Benzinga Newsdesk | September 11, 2025 08:36am